| Literature DB >> 32423038 |
Xiaosheng Dong1, Xiangren Yi1, Meng Ding2, Zan Gao3, Daniel J McDonough3, Nuo Yi4, Wenzhen Qiao5.
Abstract
Purpose: Breast cancer patients in treatment suffer from long-term side effects that seriously influence their physical and mental health. The aim of this study was to examine effectiveness of a 12-week multicomponent exercise (ME) with remote guidance intervention on health-related outcomes after one year among breast cancer patients.Entities:
Keywords: breast cancer; cardiorespiratory endurance; muscle strength; physical activity; quality of life
Year: 2020 PMID: 32423038 PMCID: PMC7277866 DOI: 10.3390/ijerph17103425
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Consolidated standards of reporting trials flowchart of the 2 arms of the study.
Participants’ characteristics at baseline and differences between groups.
| Variable | All Participants Tested at Baseline | Completers 1-Year Post-Intervention | ||||
|---|---|---|---|---|---|---|
| Total | ME | UC | Total | ME | UC | |
|
| ||||||
| Age (years) | 51.2 (7.9) | 50.4 (7.4) | 52.0 (8.5) | 50.7 (7.0) | 48.8 (5.7) | 52.8 (7.8) |
| Weight (kg) | 62.9 (7.39) | 61.6 (6.32) | 64.3 (8.21) | 62.9 (7.87) | 61.3 (6.53) | 64.7 (6.95) |
| Height (m) | 1.6 (0.05) | 1.6 (0.06) | 1.6 (0.06) | 1.6 (0.04) | 1.6 (0.05) | 1.6 (0.04) |
| BMI | 24.57 (2.60) | 24.17 (2.07) | 24.98 (3.02) | 24.55 (2.48) | 23.89 (2.01) | 25.27 (2.77) |
|
| ||||||
| Married | 37/44 | 19 (82.6%) | 18 (85.7%) | 39/44 | 20 (87.0%) | 19 (90.5%) |
| Single | 7/44 | 4 (17.4%) | 3 (14.3 %) | 5/44 | 3 (13.0%) | 2 (9.5%) |
|
| ||||||
| SBP at rest (mmHg) | 121.3 (20.6) | 117.7 (15.8) | 125.0 (24.3) | 121.6 (17.2) | 118.3 (13.9) | 125.3 (19.9) |
| DBP at rest (mmHg) | 75.4 (10.6) | 77.0 (11.0) | 73.9 (10.2) | 76.1 (10.0) | 77.0 (11.2) | 75.2 (8.6) |
| Mean Blood Pressure | 90.7 (12.6) | 90.5 (11.6) | 90.9 (13.7) | 91.3 (10.8) | 90.7 (11.0) | 91.9 (10.9) |
|
| ||||||
| I | 18/60 | 8 (26.7%) | 10 (33.3%) | 16/44 | 6 (26.1%) | 10 (47.6%) |
| Ⅱ | 33/60 | 19 (63.3%) | 14 (46.7%) | 23/44 | 15 (65.2%) | 8 (38.1%) |
| Ⅲ | 9/60 | 3 (10.0%) | 6 (20.0%) | 5/44 | 2 (8.7%) | 3 (14.3%) |
|
| ||||||
| Observation | 7/44 | 3 (13.0%) | 4 (19.0%) | 5/44 | 2 (8.7%) | 3 (14.3%) |
| Chemotherapy | 15/44 | 7 (30.4%) | 8 (38.1%) | 18/44 | 9 (39.1%) | 9 (42.9%) |
| Radiation therapy | 1/44 | 1 (4.3%) | 0(0%) | 0/44 | 0 (0%) | 0 (0%) |
| Radio-chemotherapy | 21/44 | 12 (52.2%) | 9 (42.9%) | 20/44 | 12 (52.2%) | 8 (38.1%) |
SD, standard deviation; ME, multicomponent exercise group; UC, usual care group; BMI, Body Mass Index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PT, Phase of Treatment; KG, Kilogram. Values are n, mean (SD), or as otherwise indicated. Statistical evaluations were made by Analysis of Variance.
Quality of life 1-year post-baseline.
| Variables | Group | Baseline | 1 Year | Baseline to 1 Year | ||
|---|---|---|---|---|---|---|
| Between-Group Differences Mean Change (95% CI) | ES | |||||
| SF-36 | ||||||
| PF | ME | 82.61 (11.27) | 90.00 (8.12) | 3.219 (−2.969, 9.408) | 0.155 | 0.305 |
| UC | 78.81 (20.24) | 79.76 (22.83) | ||||
| RP | ME | 29.35 (36.66) | 67.39 (32.36) | 16.046 (−0.570, 32.661) | 0.288 | 0.058 |
| UC | 58.33 (44.25) | 64.29 (42.26) | ||||
| BP | ME | 72.17 (13.80) | 80.43 (11.07) | −0.631 (−6.932, 5.669) | −0.030 | 0.843 |
| UC | 72.38 (18.95) | 81.90 (14.70) | ||||
| GH | ME | 65.61 (16.71) | 75.61 (19.06) | 3.786 (−4.287, 11.859) | 0.140 | 0.355 |
| UC | 56.38 (19.36) | 58.81 (23.68) | ||||
| VT | ME | 61.96 (12.41) | 80.65 (15.69) | 5.776 (0.987, 10.565) | 0.360 | 0.018 * |
| UC | 63.81 (7.05) | 70.95 (13.47) | ||||
| SF | ME | 88.04 (17.87) | 105.98 (22.57) | 1.527 (−7.750, 10.804) | 0.049 | 0.745 |
| UC | 84.52 (25.28) | 99.40 (26.95) | ||||
| RE | ME | 63.77 (41.33) | 79.71 (35.87) | 3.996 (−12.661, 20.654) | 0.072 | 0.636 |
| UC | 55.56 (43.89) | 63.33 (40.32) | ||||
| MH | ME | 51.48 (6.19) | 78.78 (16.90) | 9.938 (4.146, 15.729) | 0.512 | 0.001 ** |
| UC | 52.76 (6.53) | 60.19 (25.06) | ||||
| HT | ME | 3.52 (1.04) | 4.13 (0.87) | 0.281 (−0.141, 0.702) | 0.198 | 0.191 |
| UC | 3.43 (1.25) | 3.48 (0.87) | ||||
SD, standard deviation; CI, confidence interval; ME, multicomponent exercise group; UC, usual care group; SF-36, the Mos 36-item Short Form Health Survey; PF, Physical Functioning; RP, Role-Physical; BP, Bodily Pain; GH, General Health; VT, Vitality; SF, Social Functioning; RE, Role-Emotional; MH, Mental Health; HT, Reported Health Transition; ES effect size; * p < 0.05 and ** p < 0.01.
Physical Activity (PA) estimates, muscle strength, and cardiopulmonary endurance 1-year post-baseline.
| Variables | Group | Baseline | 1 Year | Baseline to 1 Year | ||
|---|---|---|---|---|---|---|
| Between-Group Differences Mean Change (95% CI) | ES | |||||
| SPSDCT | ME | 14.96 (2.96) | 22.48 (4.87) | 2.880 (1.337, 4.423) | 0.557 | 0.000 ** |
| UC | 15.57 (2.66) | 17.33 (3.31) | ||||
| ALT | ME | 15.91 (4.99) | 22.26 (3.85) | 2.745 (1.076, 4.415) | 0.491 | 0.001 ** |
| UC | 19.05 (3.29) | 19.90 (3.43) | ||||
| VO2max | ME | 41.82 (18.89) | 51.72 (16.91) | 2.500 (−4.213, 9.213) | 0.111 | 0.462 |
| UC | 42.78 (18.04) | 47.76 (14.08) | ||||
| PA Estimates | ||||||
| Social support | ME | 15.83 (5.33) | 18.04 (4.41) | 0.228 (−2.036, 2.492) | 0.030 | 0.843 |
| UC | 13.38 (6.79) | 15.14 (5.93) | ||||
| PA hinder | ME | 27.17 (4.75) | 45.65 (6.04) | 5.120 (1.976, 8.264) | 0.486 | 0.002 ** |
| UC | 28.57 (5.27) | 36.81 (7.45) | ||||
| EA | ME | 34.83 (2.19) | 36.65 (3.98) | 0.461 (−1.188, 2.110) | 0.083 | 0.581 |
| UC | 34.57 (4.95) | 35.48 (2.96) | ||||
| PA enjoyment | ME | 17.39 (2.02) | 18.43 (2.69) | 0.093 (−0.903, 1.089) | 0.028 | 0.853 |
| UC | 17.76 (3.02) | 18.62 (1.56) | ||||
| Self-efficacy | ME | 70.52 (19.65) | 71.52 (14.14) | −1.524(−10.502, 7.454) | −0.051 | 0.738 |
| UC | 57.67 (25.38) | 61.71 (24.72) | ||||
SD, standard deviation; CI, confidence intervals; ME, multicomponent exercise group; UC, usual care group; EA, expected accomplishments; VO2, max maximal oxygen uptake; SPSDCT, stand-up and sit-down chair test (number of times standing up from the chair within 30 s); ALT, arm lifting test (30 s dumbbell of 5 pounds or 2.3 kg lifting test); ES, effect size; ** p < 0.01.